layn 桂林莱茵生物科技股份有限公司 Securities Code: 002166 Securities Abbreviation: Rhine Biology Announcement No.: 2026-026 Guilin Rhine Biology Technology Co., Ltd. Announcement on the Termination of the Agreement Transfer and Control Change Matter by the Controlling Shareholder
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Guilin Rhine Biology Technology Co., Ltd. (hereinafter referred to as the "Company") received on June 22, 2026, the "Termination Agreement for the Agreement on Share Transfer, Framework Agreement on Control Change, and Agreement on Waiver of Voting Rights" (hereinafter referred to as the "Termination Agreement") signed by Mr. Qin Benjun and Guangzhou Defu Nutrition Investment Partnership (Limited Partnership) (hereinafter referred to as "Guangzhou Defu Nutrition"). Due to changes in market conditions, both parties have mutually agreed to terminate the Company's control change matter. The relevant matters are hereby announced as follows:
I. Basic Situation of the Agreement Transfer and Control Change Matter